Plain-English translation of NCT07415044 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with moderate to severe ulcerative colitis—a condition that causes inflammation and bleeding in the colon. The medication is taken by mouth, and researchers want to understand whether it works better than placebo (a dummy pill) and whether it's safe. About 1,400 adults with ulcerative colitis will participate over roughly two years.
Many people with ulcerative colitis don't respond well to current treatments or stop responding over time. This medication represents a new approach, and the trial is designed to see if it can help patients whose UC remains active despite other medicines.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either the new medication at one of two doses or a placebo pill by mouth, and the study will last up to about two years (excluding an initial screening period). You'll have regular visits where your doctors will check your symptoms, do blood tests, and may perform colonoscopies to see how well the treatment is working. Some visits will be in person at the clinic, and the study team will monitor your overall health and any side effects throughout.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States